With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis.
CONCLUSIONS: Compared to CCRT alone, consolidation chemotherapy did not further prolong progression-free survival and overall survival for patients with stage II-III squamous cell carcinoma of the esophagus. The role of consolidation therapy needs to be studied further.
PMID: 29122362 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Chen Y, Guo L, Cheng X, Wang J, Zhang Y, Wang Y, Ke S, Shi W Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Radiology | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology